Paper39174604
Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST).
Tsujinaka H and 13 others. Sci Rep, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST). Papers, record 39174604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39174604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST).
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macular Edema | Major topic |
| Taxoids | Major topic |
| Visual Acuity | Major topic |
| Humans | |
| Female | |
| Male | |
| Aged | |
| Retrospective Studies | |
| Japan | |
| Middle Aged | |
| Incidence | |
| Prognosis | |
| Bridged-Ring Compounds | |
| Aged, 80 and over | |
| Antineoplastic Agents | |
| Docetaxel | |
| Paclitaxel | |
| Retina |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30156164 | Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory. | Curr Drug Saf | 2019 | https://conductscience.org/library/papers/30156164 | PubMed |
| 2 | 25170855 | Choroidal thickness in clinically significant pseudophakic cystoid macular edema. | Retina | 2015 | https://conductscience.org/library/papers/25170855 | PubMed |
| 3 | 28868019 | Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review. | Case Rep Oncol | 2017 | https://conductscience.org/library/papers/28868019 | PubMed |
| 4 | 23154489 | Topical dorzolamide therapy for taxane-related macular oedema. | Eye (Lond) | 2013 | https://conductscience.org/library/papers/23154489 | PubMed |
| 5 | 35857057 | Nab-Paclitaxel related cystoid macular edema. | Clin Ter | 2022 | https://conductscience.org/library/papers/35857057 | PubMed |
| 6 | 23061416 | Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab. | J Ocul Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23061416 | PubMed |
| 7 | 37434856 | A meta-analysis of the incidence and risk of skin toxicity with nab-paclitaxel and paclitaxel in cancer treatment. | Am J Transl Res | 2023 | https://conductscience.org/library/papers/37434856 | PubMed |
| 8 | 10071301 | Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10071301 | PubMed |
| 9 | 24564293 | Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report. | BMC Ophthalmol | 2014 | https://conductscience.org/library/papers/24564293 | PubMed |
| 10 | 9402182 | Ophthalmic toxicity following paclitaxel infusion. | Ann Oncol | 1997 | https://conductscience.org/library/papers/9402182 | PubMed |
| 11 | 5553076 | Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. | J Am Chem Soc | 1971 | https://conductscience.org/library/papers/5553076 | PubMed |
| 12 | 22592399 | Cystoid macular edema induced by nab-paclitaxel. | Breast Cancer | 2015 | https://conductscience.org/library/papers/22592399 | PubMed |
| 13 | 30381669 | Risk Factors for Eye Disorders Caused by Paclitaxel: A Retrospective Study. | Biol Pharm Bull | 2018 | https://conductscience.org/library/papers/30381669 | PubMed |
| 14 | 19668445 | Cystoid macular edema. | Clin Ophthalmol | 2008 | https://conductscience.org/library/papers/19668445 | PubMed |
| 15 | 25764317 | Cystoid macular edema and macular pigmentation associated with nab-Paclitaxel therapy. | Retin Cases Brief Rep | 2015 | https://conductscience.org/library/papers/25764317 | PubMed |
| 16 | 9205828 | The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication. | Br J Clin Pharmacol | 1997 | https://conductscience.org/library/papers/9205828 | PubMed |
| 17 | 31112878 | Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis. | Crit Rev Oncol Hematol | 2019 | https://conductscience.org/library/papers/31112878 | PubMed |
| 18 | 31755455 | Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema. | Indian J Ophthalmol | 2019 | https://conductscience.org/library/papers/31755455 | PubMed |
| 19 | 35951320 | Risk of Ocular Adverse Events With Taxane-Based Chemotherapy. | JAMA Ophthalmol | 2022 | https://conductscience.org/library/papers/35951320 | PubMed |
| 20 | 19001234 | Cystoid macular edema secondary to albumin-bound paclitaxel therapy. | Arch Ophthalmol | 2008 | https://conductscience.org/library/papers/19001234 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42559568 | Nab-Paclitaxel-Induced Cystoid Macular Edema with Minimal Fluorescein Leakage: A Case Report of Two Patients from a Tertiary Referral Center. | Case Rep Ophthalmol | 2026 | https://conductscience.org/library/papers/42559568 | PubMed |
| 42525694 | Real‑world analysis of Macular Oedema associated with Paclitaxel Formulations using the Japanese Adverse Drug Event Report database. | PLoS One | 2026 | https://conductscience.org/library/papers/42525694 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39174604
GET https://conductscience.org/api/papers/v1/39174604/references?page=2